Eileen O'Meara Selected Research

Transjugular Intrahepatic Portasystemic Shunt

1/2021	CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction.
1/2020	CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis.
3/2016	The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice.
1/2015	The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implications.
3/2014	The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: focus on rehabilitation and exercise and surgical coronary revascularization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eileen O'Meara Research Topics

Disease

106	Heart Failure 03/2024 - 08/2004
8	Atrial Fibrillation 03/2024 - 01/2010
7	Heart Arrest (Cardiac Arrest) 11/2021 - 04/2014
6	Iron Deficiencies 01/2024 - 12/2010
6	Cardiomyopathies (Cardiomyopathy) 12/2023 - 12/2019
6	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2019
5	Left Ventricular Dysfunction 02/2024 - 10/2011
5	Inflammation (Inflammations) 01/2024 - 01/2012
5	Chronic Renal Insufficiency 01/2022 - 12/2010
5	Hyperkalemia 01/2019 - 04/2014
5	Anemia 01/2015 - 12/2004
4	Myocardial Infarction 01/2022 - 12/2007
4	Hypokalemia 01/2019 - 04/2014
3	Fibrosis (Cirrhosis) 01/2023 - 12/2011
3	Stroke (Strokes) 01/2022 - 01/2020
3	Systolic Heart Failure 01/2021 - 11/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 11/2017
2	Frailty 01/2023 - 01/2020
2	Heart Diseases (Heart Disease) 01/2022 - 01/2018
2	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2020 - 10/2017
2	Hypertension (High Blood Pressure) 12/2019 - 05/2012
2	Death (Near-Death Experience) 11/2017 - 05/2011
1	Dyspnea (Shortness of Breath) 01/2024
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2024
1	Cardio-Renal Syndrome 01/2023
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2023
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 10/2022
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2022
1	Gout 01/2022
1	Hypoglycemia (Reactive Hypoglycemia) 01/2021
1	Ketosis 01/2021
1	Amyloidosis 01/2020
1	Transthyretin-Related Hereditary Amyloidosis 01/2020
1	Pulmonary Hypertension 12/2019

Drug/Important Bio-Agent (IBA)

27	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 12/2011
23	dapagliflozinIBA 12/2023 - 11/2019
18	Spironolactone (Aldactone)FDA LinkGeneric 01/2022 - 08/2004
15	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2012
8	Natriuretic PeptidesIBA 12/2023 - 09/2014
8	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 12/2013
8	candesartanIBA 12/2019 - 11/2004
7	sacubitril and valsartan sodium hydrate drug combinationIBA 07/2023 - 01/2018
6	Neprilysin (Neutral Endopeptidase)IBA 03/2024 - 01/2015
6	Angiotensin Receptors (Angiotensin II Receptor)IBA 03/2024 - 01/2015
6	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 10/2018
5	omecamtiv mecarbilIBA 12/2023 - 11/2020
5	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 11/2019
5	Sodium-Glucose Transport ProteinsIBA 01/2022 - 11/2019
5	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 09/2014
5	CreatinineIBA 11/2018 - 12/2010
4	ferric carboxymaltoseIBA 01/2024 - 01/2021
4	SodiumIBA 01/2023 - 01/2020
4	Troponin T (Troponin T1)IBA 01/2022 - 09/2014
4	DiureticsIBA 01/2020 - 12/2013
4	IvabradineIBA 12/2019 - 10/2011
4	Angiotensin Receptor AntagonistsIBA 05/2018 - 11/2004
3	paragonIBA 02/2024 - 01/2018
3	IronIBA 12/2023 - 12/2010
3	Cardiac MyosinsIBA 01/2021 - 11/2020
2	omega-Chloroacetophenone (Mace)IBA 01/2024 - 01/2022
2	Growth Differentiation Factor 15IBA 01/2023 - 12/2018
2	Ferritins (Ferritin)IBA 01/2022 - 12/2010
2	TroponinIBA 01/2022 - 11/2018
2	Transferrin (beta 2 Transferrin)IBA 01/2022 - 12/2010
2	Transferrin Receptors (Transferrin Receptor)IBA 01/2022 - 12/2010
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 01/2022
2	Irbesartan FDA LinkGeneric 12/2019 - 01/2017
2	Enalapril FDA LinkGeneric 01/2019 - 12/2018
2	Hemoglobins (Hemoglobin)IBA 05/2018 - 02/2006
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2018 - 05/2012
2	PotassiumIBA 05/2018 - 01/2015
2	AnticoagulantsIBA 01/2016 - 05/2012
1	C-Reactive ProteinIBA 01/2024
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2024
1	CarbohydratesIBA 11/2023
1	AntigensIBA 11/2023
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2023
1	Clostridium perfringens epsilon-toxinIBA 01/2022
1	SymportersIBA 01/2022
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	Erythropoietin FDA Link 01/2022
1	HepcidinsIBA 01/2022
1	Carbon DioxideIBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2021
1	Galectin 3 (LGALS3)IBA 01/2021
1	Collagen Type III (Type III Collagen)IBA 01/2021
1	Prealbumin (Transthyretin)IBA 01/2020
1	tafamidisIBA 01/2020

Therapy/Procedure

35	Therapeutics 03/2024 - 12/2004
5	Transjugular Intrahepatic Portasystemic Shunt 01/2021 - 03/2014
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2022
3	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 05/2012
2	Cardiac Resynchronization Therapy 10/2017 - 12/2011
1	Contraindications 01/2023
1	Patient Readmission 10/2022
1	Polypharmacy 11/2021
1	Surgical Amputation (Amputations) 01/2021
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2019